Skip to main content

Hand Osteoarthritis

1
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Marius Pharmaceuticals
1 program
1
MetforminPhase 31 trial
Active Trials
NCT06367283Recruiting150Est. Apr 2026
Bioiberica
BioibericaSpain - Barcelona
1 program
DroglicanPHASE_41 trial
Active Trials
NCT02823548Unknown330Est. Jul 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BioibericaDroglican
Marius PharmaceuticalsMetformin

Clinical Trials (2)

Total enrollment: 480 patients across 2 trials

Primary Care Study With Chondroitin Sulfate and Glucosamine Hydrochloride in Hand Osteoarhritis

Start: Aug 2016Est. completion: Jul 2017330 patients
Phase 4Unknown

Metformin Treatment of Patients with Hand Osteoarthritis

Start: Jun 2024Est. completion: Apr 2026150 patients
Phase 3Recruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs, potential near-term approvals
1 actively recruiting trials targeting 480 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.